NCT02292147 (HANOX) is a clinical trial in Out of Hospital Cardiac Arrest, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT02292147?

NCT02292147 is sponsored by Assistance Publique - Hôpitaux de Paris.

What condition does NCT02292147 study?

NCT02292147 studies Out of Hospital Cardiac Arrest.

Is NCT02292147 still recruiting?

NCT02292147 is currently completed. Last updated 19 August 2020.

Last reviewed 2020-08-19 · How we verify

NCT02292147: HANOX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional Outcome After Cardiac Arrest

Completed Last updated 19 August 2020

What this trial tests

trial in Out of Hospital Cardiac Arrest in 140 participants. Completed in 20 October 2017.

Timeline

13 March 2013

Primary endpoint
20 October 2017

20 October 2017

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	140
Start date	13 March 2013
Primary completion	20 October 2017
Estimated completion	20 October 2017
Sites	1 location across France

Conditions studied

Out of Hospital Cardiac Arrest — all drugs for Out of Hospital Cardiac Arrest →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 18 to 85, any sex, with Out of Hospital Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Descriptive and prognosis study of the functional outcome after cardiac arrest for the patients awake within the first 15 days.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-Term Disabilities of Survivors of Out-of-Hospital Cardiac Arrest: The Hanox Study.
Peskine A, Cariou A, Hajage D, Deye N, et al · · 2021 · cited 24× · PMID 32702410 · DOI 10.1016/j.chest.2020.07.022

Verify or expand the search:

Other recruiting trials for Out of Hospital Cardiac Arrest

Currently open trials in the same condition.

NCT06789978 — Rapid Prehospital ACcess to ECPR in Prague · NA · recruiting
NCT06856018 — Artificial Intelligence Cerebral Gray-white Matter Ratio Module Usage in Hsinchu District Hsinchu District Using an Arti · active not recruiting
NCT05917717 — Cardiac Arrest Bundle of cARE Trial · NA · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02292147 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 19 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02292147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing